Drop in biological initiation for patients with psoriasis during the COVID-pandemic.

Biologics have become the backbone of chronic inflammatory diseases treatment, including psoriasis. Post-approval studies allowed to better understand their safety profile demonstrating a favorable risk-benefit ratio despite an increased risk […]